Compare MobilEye Global Inc (MBLY) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Recursion Pharmaceuticals Inc — how do they compare? MobilEye Global Inc trades at $9.01 (market cap $7.54B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: MobilEye Global Inc is far larger — about 4.9× Recursion Pharmaceuticals Inc's market cap, and MobilEye Global Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| MBLY | RXRX | |
|---|---|---|
Market Cap | $7.54B | $1.53B |
Sector | Technology | Health |
52-Week High | $16.19 | $6.79 |
52-Week Low | $6.56 | $2.84 |
Enterprise Value | $6.19B | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
